Effectiveness of Fludarabine, Idarubicin and Cyclophosphamide (FLUIC) Combination Regimen for Young Patients with Untreated Non-Follicular Low-Grade Non-Hodgkin's Lymphoma

References

• Wotherspoon, A.C., Doglioni, C., Diss, T.C., Pan, L., Moschini, A., de Boni, M., et al. (1993) "Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori", Lancet, 342, 575 — 577.
   Google Scholar
• Schechter, N.R., Portlock, C.S. and Yahalom, J. (1998) "Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone", J. Clin. °flea, 16, 1916— 1921.
   Google Scholar
• Zinzani, P.L., Tani, M., Barbieri, E., Stefoni, V., Alinari, L. and Baccarani, M. (2003) "Utility of surgical resection with or without radiation therapy in patients with low-grade gastric mucosa-associated lymphoid tissue lymphoma", Haematologica, 88, 830 — 831.
   Google Scholar
• Portlock, CS., Rosenberg, S.A., Glatstein, E. and Kaplan, H.S. (1976) "Treatment of advanced non-Hodgkin's lymphomas with favourable histologies: preliminary results of a prospective trial", Blood, 47, 747–756.
   Google Scholar
• Hoppe, R.T., Kushlan, P., Kaplan, H.S., Rosenberg, S.A. and Brown, B.W. (1981) "The treatment of advanced stage favourable histology non-Hodgkin's lymphoma: a preliminary report of a randomized trial comparing single agent chemotherapy, combina-tion chemotherapy, and whole body irradiation", Blood, 58, 592 — 598.
   Google Scholar
• Horning, S.J. and Rosenberg, S.A. (1984) "The natural history of initially untreated low-grade non-Hodgkin's lymphomas", N. EngL J. Med., 311, 1471 — 1475.
   Google Scholar
• Redman, J.R., Cabanillas, F., Velasquez, W.S., McLaughlin, P., Hagemeister, F.B., Swan, F. Jr., et al. (1992) "Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma", J. Clin. °flea, 109, 790–794.
   Google Scholar
• Hochster, H.S., Kim, K., Green, M.D., Mann, R.B., Neiman, R.S., Oken, M.M., et al. (1992) "Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study", J. Clin. °flea, 10, 28— 32.
   Google Scholar
• Zinzani, P.L., Lauria, F., Rondelli, D., Benfenati, D., Raspadori, D., Bocchia, M., et al. (1993) "Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma", Ann. °flea, 4, 575–578.
   Google Scholar
• Hiddemann, W., Unterhalt, M., Pott, C., Wormann, B., Sanford, D., Freund, M., et al. (1993) "Fludarabine single-agent therapy for relapsed low-grade non-Hodgkin's lymphomas: a phase II study of the German low-grade non-Hodgkin's lymphoma study group", Semin. Oncol., 20, 28–31.
   Google Scholar
• McLaughlin, P., Hagemeister, F.B., Swan, F., et al. (1994) "Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma", J. Clin. °flea, 12, 575–579.
   Google Scholar
• Zinzani, P.L., Bendandi, M. and Tura, S. (1995) "FMP regimen (fludarabine, mitoxantrone, prednisone) as therapy in recurrent low-grade non-Hodgkin's lymphoma", Eur. J. Haematol., 55, 262–266.
   Google Scholar
• McLaughlin, P., Hagemeister, F.B., Ramaguera, J.E., Sarris, A.H., Pate, 0., Younes, A., et al. (1996) "Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma", J. Clin. Oncol., 14, 1262— 1268.
   Google Scholar
• Zinzani, P.L., Bendandi, M., Magagnoli, F., Gherlinzoni, F., Merla, E. and Tura, S. (1997) "Fludarabine-mitoxantrone combination-containing regimen in recurrent low-grade non-Hodgkin's lympho-ma", Ann. Oncol., 8, 379–383.
   Google Scholar
• Zinzani, P.L., Magagnoli, M., Bendandi, M., Gherlinzoni, F., Orcioni, G.F., Cellini, C., et al. (2000) "Efficacy of fludarabine and mitoxantrone (FN) combination regimen in untreated indolent non-Hodgkin's lymphomas", Ann. Oncol., 11, 363–365.
   Google Scholar
• Zinzani, P.L., Bendandi, M., Gherlinzoni, F., Merla, E., Gozzetti, A. and Tura, S. (1996) "FLU-ID (fludarabine and idarubicin) regimen as salvage therapy in pretreated low-grade non-Hodgkin's lymphoma", Haematologica, 81, 168 — 171.
   Google Scholar
• Zinzani, P.L., Magagnoli, M., Moretti, L., De Renzo, A., Battista, R., Zaccaria, A., et al. (2000) "Randomized trial of fludarabine versus fludarabine and idarubicin as front-line treatment in patients with indolent or mantle cell lymphoma", J. Clin. Oncol., 18, 773 — 779.
   Google Scholar
• Hochster, H.S., Oken, M.M., Winter, J.N., Gordon, L.I., Raphael, B.G., Bennett, J.M., etal. (2000) "Phase I study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma: results and long-term follow-up—a report from the Eastern Cooperative Oncology Group", J. Clin. Oncol., 18, 987 — 994.
   Google Scholar
• Flinn, I.W., Byrd, J.C., Morrison, C., Jamison, J., Diehl, L.F., Murphy, T., et al. (2000) "Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies", Blood, 96, 71–75.
   Google Scholar
• Lazzarino, M., Orlandi, E., Montillo, M., Tedeschi, A., Pagnucco, G., Astori, C., et al. (1999) "Fludarabine, cyclophosphamide, and dexamethasone (FLuCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphoma", Ann. Oncol., 10, 59 — 64.
   Google Scholar
• Harris, N.L., Jaffe, ES., Stein, H., Banks, P.M., Chan, J.K., Cleary, ML., et al. (1994) "A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group", Blood, 84, 1361 — 1392.
   Google Scholar
• Carbone, P.P., Kaplan, H.S., Musshof, K., Smithers, D.W. and Tubiana, M. (1971) "Report of the committee on Hodgkin's disease staging classification", Cancer Res., 31, 1860 — 1861.
   Google Scholar
• Oken, M., Creech, R., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., et al. (1982) "Toxicity and response criteria of the Eastern Cooperative Oncology Group", Am. J. Clin. Oncol., 5, 649–655.
   Google Scholar
• Cheson, B.D., Horning, Si., Coiffier, B., Shipp, M.A., Fisher, RI., Connors, J.M., et al. (1999) "Report of an International Workshop to standardize response criteria for non-Hodgkin's lymphomas", J. Clin. Oncol., 17, 1244 — 1253.
   Google Scholar
• Kaplan, E.L. and Meier, P. (1958) "Non-parametric estimation from incomplete observations", J. Am. Stat. Assoc., 53, 457 —481.
   Google Scholar
• Shipp, M., Harrington, D. and Anderson, J. (1993) "A predictive model for aggressive non-Hodgkin's lymphoma", N. Engl. J. Med., 329, 987–994.
   Google Scholar
• Young, R.C., Longo, DL., Glatstein, E., Ihde, D.C., Jaffe, E.S. and DeVita, V.T. Jr. (1988) "The treatment of indolent lymphomas: watchful waiting versus aggressive combined modality treatment", Semin. Hematol., 25\(suppl 2), 11–16.
   Google Scholar
• Lepage, E., Sebban, C., Gisselbrecht, C., Coiffier, B., Harousseau, J.L., Byron, P.A., et al. (1990) "Treatment of low-grade non-Hodgkin's lymphomas: assessment of doxorubicin in a controlled trial", Hematol. Oncol., 8, 31— 39.
   Google Scholar
• Haas, R., Moos, M., Karcher, A., Mohle, R., Witt, B., Gold-schmidt, H., et al. (1994) "Sequential high-dose therapy with peripheral blood progenitor cell support in low-grade non-Hodgkin's lymphoma", J. Clin. Oncol., 12, 1685— 1692.
   Google Scholar
• McLaughlin, P., Grillo-Lopez, A.J., Link, BK., Levy, R., Czucz-man, M.S., Williams, ME., et al. (1998) "IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program", J. Clin. Oncol., 16, 2825–2833.
   Google Scholar
• Czuczman, M.S., Fallon, A., Mohr, A., Stewart, C., Bernstein, Z.P., McCarthy, P., et al. (2002) "Rituximab in combination with CHOP or fludarabine in low-grade lymphoma", Semin. Oncol., 29, 36–40.
   Google Scholar
• Witzig, T.E., White, C.A., Wiseman, GA., Gordon, L.I., Emma-nouilides, C., Raubitschek, A., et al. (1999) "Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20( + ) B-cell non-Hodgkin's lymphoma", J. Clin. Oncol., 17, 3793 — 3803.
   Google Scholar
• Witzig, T.E., Flinn, I.W., Gordon, L.I., Emmanouilides, C., Czuczman, M.S., Saleh, M.N., et al. (2002) "Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with ritux-imab-refractory follicular non-Hodgkin's lymphoma", J. Clin. Oncol., 20, 3262–3269.
   Google Scholar